Additionally, GC cells expressing IRF2BP2 shRNA were inoculated subcutaneously in mice to construct xenograft models, and the results showed that knocking down IRF2BP2 significantly inhibited tumor growth. The gene discussed is IRF2BP2; the disease is neoplasm.